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Abstract
Background: People with severe mental illness have poorer physical health, experience disparities in physical
health care, and lead significantly shorter lives, compared to the general population. Routine metabolic monitoring
is proposed as a method of identifying risk factors for metabolic abnormalities. Efforts to date suggest routine
metabolic monitoring is both incomplete and ad-hoc, however. This present study reports on the recent
implementation of a routine metabolic monitoring form at a mental health service in regional Australia.
Methods: A retrospective file audit was undertaken on 721 consumers with electronic health records at the mental
health service. Descriptive statistics were used to report the frequency of use of the metabolic monitoring form and
the range of metabolic parameters that had been recorded.
Results: Consumers had an average age of 41.4 years (SD = 14.6), over half were male (58.4 %), and the most
common psychiatric diagnosis was schizophrenia (42.3 %). The metabolic monitoring forms of 36 % of consumers
contained data. Measurements were most commonly recorded for weight (87.4 % of forms), height (85.4 %), blood
pressure (83.5 %), and body mass index (73.6 %). Data were less frequently recorded for lipids (cholesterol, 56.3 %;
low density lipoprotein, 48.7 %; high density lipoprotein, 51.7 %; triglycerides, 55.2 %), liver function (alanine
aminotransferase, 66.3 %; aspartate aminotransferase, 65.5 %; gamma-glutamyl transpeptidase, 64.8 %), renal
function (urea, 66.3 %; creatinine, 65.9 %), fasting blood glucose (60.2 %), and waist circumference (54.4 %).
Conclusions: The metabolic monitoring forms in consumer electronic health records are not utilised in a manner
that maximises their potential. The extent of the missing data suggests that the metabolic health of most
consumers may not have been adequately monitored. Addressing the possible reasons for the low completion rate
has the potential to improve the provision of physical health care for people with mental illness.
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Background
People with severe mental illnesses (SMI) -such as
schizophrenia, bipolar disorder, and major depressive
disorder - have substantially poorer physical health than
the general population [1, 2]. They are at increased risk
of many physical health problems, including cardio-
vascular diseases, obesity, metabolic syndrome, and
dyslipidaemia [1]. As a result, people with SMI have a
reduced life expectancy of between 1.4 and 32 years
(median = 10.1 years) [3]. Several lifestyle behaviours
(e.g., unhealthy diets, physical inactivity, smoking, al-
cohol and drug use, and unsafe sex) are known to be
contribute to this reduction in life expectancy [4]. In
addition, anti-psychotic medication and other psycho-
tropic drugs are known to be major contributors to
the ill-health of people with SMI [5–9]. Many factors
contributing to the increased risk of cardiovascular
and all-cause mortality in people with SMI are modifi-
able, however [10]. Health care providers, including
mental health services, have an important role in
identifying and monitoring these risks [11].* Correspondence: r.stanton@cqu.edu.au2School of Medical and Applied Sciences, Central Queensland University,
Bruce Highway, North Rockhampton, QLD 4702, Australia
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The provision of inadequate health care for people
with SMI is a major form of inequality [12, 13]. Moni-
toring of risk factors for poor cardiometabolic health
(known as metabolic monitoring) would represent a sig-
nificant step towards equity in health care provision
[14]. As in the general populations, metabolic monitor-
ing in people with SMI is necessary to quantify the risk
of cardiovascular disease and diabetes, and initiate early
interventions for risk management [15].
Internationally, the level of comprehensive metabolic
care offered to people with mental illness is consistently
found to be inadequate [16]. Research included in this
review comparing the quality of care of people with and
without mental illness, showed that people with mental
illness taking anti-psychotic medications were 30 % less
likely to have their weight, blood glucose, and lipids
assessed [16]. Using chart reviews, clinical and adminis-
trative data, Littman et al. [17] estimated rates of screen-
ing for obesity (defined by body mass index) to be
between 94 – 94.7 % in a sample of 37,889 veterans from
the Veterans Health Administration in the USA. How-
ever, when multiple metabolic risks are considered,
monitoring performance is quite variable. Consistent
with this evidence, the authors of a recent review re-
ported substantial variability in the rates cardiovascular
health screening in people with SMI, which the authors
suggested were due to differences in the organization of
health care [18]. In a recent study, Cotes et al. [19]
inspected medical records within a public-funded com-
munity health service in a US state, to ascertain if an
education program on the metabolic monitoring of con-
sumers taking antipsychotics would improve monitoring
levels. They found a statistically non-significant increase
in the frequency of metabolic monitoring, even though
the program included feedback on performance at moni-
toring metabolic risks. Similarly, Saloojee et al. [20] iden-
tified that less than one per cent of outpatients at a large
South African hospital were screened on the set of risk
factors needed to identify metabolic syndrome. Poor
monitoring was occurring despite the availability of
guideline recommendations on metabolic care of people
with SMI in South Africa. Collectively, these studies
confirm the variability of metabolic monitoring practices
in several countries.
In considering the poor rate of implementation of
metabolic care activities, many health care system-
related factors (e.g., lack of role clarity within treating
teams regarding responsibility for screening, lack of con-
tinuity of care, limited time and resources for physical
and medical examinations, separation of medical and
mental health care systems) represent significant barriers
to change [21, 22]. Moreover, nurses working in mental
health have reported personal barriers to monitoring,
such as competing priorities and concerns regarding the
outcomes of screening [23]. The increased metabolic
risks for people with SMI are well documented [24], par-
ticularly for those consumers prescribed anti-psychotic
medication [1, 9]. Therefore, it is fundamental to clinical
practice to have routine and detailed metabolic monitor-
ing to track changes in risk to inform clinical decision-
making.
There is limited data on metabolic monitoring rates in
Australian mental health care services, with reports pri-
marily available from metropolitan, rather than regional
and rural, areas [25] e.g. [26]. Organ et al. [27] reported
that around 60 % of consumers files contained data on
lipid and blood glucose levels, whereas only 7 % of
consumers with SMI had their weight circumference
recorded. The absence of waist circumference measure-
ment is also reported in other studies. For example,
Rosenbaum and colleagues [28] reported that, prior to an
educational intervention for nurses highlighting the
importance of waist circumference assessment, these data
were not reported in any of the 60 randomly sampled con-
sumer files selected for auditing. Three months later, 58 %
of files contained waist circumference measurements,
while at nine months this reduced to 42 %. Although bar-
riers to waist circumference measurement (such as con-
cern regarding physical contact) exist, the study of
Rosenbaum and colleagues [28] demonstrated that educa-
tional interventions for nurses can improve the assess-
ment of cardiometabolic markers in people with SMI.
Thompson et al. [29] reported metabolic monitoring
levels of consumers with first episode psychosis on a
regimen of anti-psychotic medications in a service
adopting locally adapted monitoring guidelines. Blood
pressure data was reported in 41.6 % of files reviewed,
blood glucose data was reported in 24.4 % of cases, while
lipids were reported in 26.7 % of files. In the same 86
consumers tracked over six months, initial recordings
(screening stage) were higher – 81.4 %, 74.4 % and
75.6 % respectively - indicating efforts are needed to sus-
tain attention on metabolic risks.
To combat the poor physical health care of people
with SMI, specialist nursing roles have been proposed.
In a recent study, McKenna and colleagues [30] com-
pared rates of metabolic monitoring between a mental
health service where such a role was implemented,
with a service where no such role existed. A specialist
role led to a significant increase in the rate of meta-
bolic monitoring, compared to services where this
responsibility fell to case managers. Despite this spe-
cialist role initiating metabolic monitoring in 78 % of
first episode consumers, there were metabolic moni-
toring data missing in more than 42 % of cases, with
smoking the only parameter monitored in all cases.
In reviewing the reasons for missing data, McKenna
and colleagues note that specialist nursing staff
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identified several reasons for the missing data, includ-
ing consumer anxiety towards needles (limiting the
potential to undertake blood profiling), the complexity
of procedures for collecting fasting blood glucose,
logistical barriers to attending community-based
pathology services (e.g., timing of appointments or
transportation issues), and poor communication of
diagnostic results between the mental health service
and local medical officers.
Collectively, these studies highlight the poor use of
metabolic monitoring in metropolitan mental health ser-
vices. Such findings may well generalise to regional ser-
vices. This paper reports on metabolic monitoring in a
regionally located public mental health service within a
large state of Australia. In mid-2013, the health service
implemented a policy of routine metabolic monitoring
of all consumers using antipsychotic medications or
mood stabilisers. A standardised metabolic monitoring
form was developed to be completed and uploaded to
the electronic medical records database of consumers
accessing the service. Given the high prevalence of car-
diometabolic risk factors, and the repeated calls for rou-
tine metabolic monitoring in this population [31], the
introduction of a standardised metabolic monitoring
form represents a significant step in addressing the poor
physical health of people with mental illness. However,
the effectiveness of such a strategy remains to be evalu-
ated, particularly in regional areas. Therefore the aims of
the present study were to evaluate the frequency of use
of the routine metabolic monitoring form and to exam-
ine the degree to which the forms were completed. Such
data are important in evaluating the implementation of
routine metabolic monitoring strategies, and the out-
comes have important implications for mental health
service delivery.
Methods
Setting
This study was undertaken in a mental health service in
a city of approximately 75,000 people, located in regional
Queensland, Australia. The service provides both in-
patient and community mental health services and re-
ceives approximately 85 referrals per month.
Design
A retrospective file audit was undertaken examining the
use of the metabolic monitoring form in the regional
mental health service. Where multiple recording of
metabolic monitoring data were contained on a single
form for a consumer, the earliest data was taken as base-
line data, with subsequent entries taken as the follow up
time points.
Data
The files of 721 consumers were reviewed. The con-
sumers’ ages ranged from 13 to 83 years (M = 41.4 years,
SD = 14.6), over half were male (58.4 %), and the most
common psychiatric diagnosis was schizophrenia (42.3 %)
(see Table 1).
Metabolic monitoring form
As there is no consensus or minimum data set recom-
mendation for metabolic monitoring forms, the form de-
veloped and implemented in this service was based on
the needs of the service in consultation with clinicians.
This form enables the recording of metabolic-related
data, including anthropometrics (e.g., waist circumfer-
ence, weight), blood markers of cardiovascular and
endocrine health (e.g. triglycerides, alanine aminotrans-
ferase [ALT]), medication specific blood markers (e.g.,
valproate level, thyroid function test results, lithium
Table 1 Demographic and psychiatric diagnostic differences between consumers for whom the metabolic monitoring form had
and had not been used
Total sample (n = 721) Form used (n = 261) Form not used (n = 460) Effect size p value
Age, mean (SD) years 41.4 (14.6) 41.4 (14.3) 41.5 (14.8) d = 0.01 .902
Sex φ = .12 .001
Males, n (%) 421 (58.4) 175 (41.6) 246 (58.4)
Females, n (%) 300 (41.6) 89 (29.7) 211 (70.3)
Diagnosis (ICD-10)a Cramer’s V = .27 <.001
Schizophrenia (F20), n (%) 305 (42.3) 159 (60.7) 146 (33.1)
Bipolar disorder (F31), n (%) 84 (11.7) 23 (27.4) 61 (72.6)
Depressive disorders (F32, F33), n (%) 81 (11.2) 17 (21.0) 64 (79.0)
Anxiety disorders (F41), n (%) 40 (5.5) 7 (17.5) 33 (82.5)
Other, n (%) 193 (26.8) 56 (29.0) 137 (71.0)
aDiagnosis data were missing for 18 (2.5 %) consumers
SD standard deviation; ICD- 10
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levels), and electrocardiogram findings (e.g., rate, rhythm,
abnormality). Data recorded on the form are uploaded to
consumers’ electronic health records.
Procedures
The data collection occurred between November 2014
and April 2015 and included all consumer electronic
health records at the service. A trained research assistant
extracted all data from consumers’ metabolic monitoring
forms to a spreadsheet. All data were de-identified and
only data that appeared on the metabolic monitoring
form was extracted.
Statistical analysis
To determine whether there were differences in the ages,
sexes, and psychiatric diagnoses of consumers for whom
the metabolic monitoring form had, and had not been
used, appropriate inferential statistics (i.e., a paired t test
for age and χ2 tests for sex and psychiatric diagnoses)
were applied. Consistent with sound statistical practices
[32, 33], effect sizes were calculated and the issue of
experiment-wise alpha inflation due to multiple tests
was addressed. Effect sizes are reported in the form of
Cohen’s d, φ, and Cramer’s V. According to Cohen’s [34]
conventions, small, medium, and large effects are 0.2,
0.5, and 0.8, respectively, for Cohen’s d and .10, .30, and
.50, respectively, for both φ and Cramer’s V. With only
three tests performed, setting alpha at .01 adequately ad-
dresses the problem of inflated experiment-wise error
due to multiple testing. To assess the extent to which
the form was being completed, descriptive statistics
(n, %) are reported.
Ethics
Ethical clearance for the conduct of this retrospective
file audit was granted by the health service (Queensland
Health) and institutional (CQUniversity) human re-
search ethics committees prior to the commencement of
this study. Health service approval was granted to access
data contained in consumer files.
Results
Metabolic monitoring forms were available for 261
(36 %) consumers. Comparing consumers where forms
were available, with those were the form was not avail-
able, there were no differences in ages, but forms were
present for higher percentages of males, and for con-
sumers with schizophrenia (see Table 1). For the 261
consumers for whom baseline data were available, 59
(22.6 %) had follow up data recorded in their forms at
three months, 87 (33.3 %) at six months, 42 (16.1 %) at
12 months, 18 (6.9 %) at 18 months, 9 (3.4 %) at
24 months, and 1 (0.4 %) at 36 months.
Data were not recorded for many of the measures in-
cluded in the form. Although height, weight, and blood
pressure were each recorded for over 80 % of con-
sumers, other data applicable to all consumers were re-
corded in half to two-thirds of forms (see Table 2). With
respect to medication-specific measures, data were re-
corded in between 1.1 % and 20.7 % of forms. Data relat-
ing to cardiac function were never recorded (see
Table 3).
Discussion
In the present study, we examined the use of an elec-
tronic metabolic monitoring form in a mental health
Table 2 Data recorded in the metabolic monitoring form at baseline
Measure Observation recorded – n (%) Observation not recorded – n (%)
Anthropometry Height 223 (85.4) 38 (14.6)
Weight 228 (87.4) 33 (12.6)
Body mass index 192 (73.6) 69 (26.4)
Waist circumference 142 (54.4) 119 (45.6)
Blood pressure Blood pressure 218 (83.5) 43 (16.5)
Fasting blood glucose Fasting blood glucose 157 (60.2) 104 (39.8)
Lipids Cholesterol 147 (56.3) 114 (43.7)
Low density lipoprotein 127 (48.7) 134 (51.3)
High density lipoprotein 153 (51.7) 126 (48.3)
Triglycerides 144 (55.2) 117 (44.8)
Liver function Alanine aminotransferase 173 (66.3) 88 (33.7)
Aspartate aminotransferase 171 (65.5) 90 (34.5)
Gamma-glutamyl transpeptidase 169 (64.8) 92 (35.2)
Renal function Urea 173 (66.3) 88 (33.7)
Creatinine 172 (65.9) 89 (34.1)
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service in regional Queensland, Australia. Few studies
have examined this aspect of mental health care, and
those published to date have similar findings to ours.
For example, Organ and colleges [27] audited 618 files
from a large metropolitan mental health service and re-
ported that there had been inconsistent recording of
cholesterol (63 % of files), blood glucose (60 % of files),
body weight (54 % of files) and blood pressure (44 % of
files). Waist circumference data was present in only 7 %
of files. More recently, Rosenbaum and colleagues [28]
reported that blood pressure was recorded on 92 % of
files and body mass index was recorded on 78 % of files,
whereas waist circumference was not reported on any of
the 60 files audited at baseline. Finally, an audit of meta-
bolic monitoring within a large metropolitan community
mental health service revealed that files contained data
on body weight (61 % of files), blood glucose (59 % of
files), lipids (49 % of files), and blood pressure (38 % of
files) [35]. In contrast to the aforementioned studies,
waist circumference was not included in the metabolic
monitoring study described by Millar and colleagues, as
this parameter was not assessed by the service. The find-
ings, both from our study and from previous work, high-
light both the lack of consensus on the parameters on
metabolic monitoring and the extent of missing data on
consumers’ physical health. This missing data was espe-
cially evident in the recording of data relating to cardiac
function, which, although detailed on the form, was not
reported in any file audited.
For over a century, the health care inequalities mental
health consumers routinely experience with respect to
their physical health needs have been consistently docu-
mented ([36, 37], e.g., [38–41]). This inadequate atten-
tion to the physical health needs of mental health
consumers is a likely contributor to the higher than ex-
pected mortality rates in this population [42]. Exposing
the magnitude and consequences of this problem pro-
vides healthcare professionals and service providers with
opportunities to gain a clearer understanding of the
challenges inherent in the care of mental health con-
sumers and to develop and trial possible solutions. Un-
fortunately, our research provides further evidence that
the problem of poor physical healthcare of mental health
consumers has not been adequately addressed.
Given the high prevalence of metabolic abnormalities,
such as hypercholesterolaemia, among mental health
consumers [43, 44], particularly those with schizophrenia
[45], the findings of this study are particularly concern-
ing. Our findings are, however, consistent with previous
research showing that metabolic risk factors are not ad-
equately monitored in mental health consumers [8].
Data had been entered into the electronic metabolic
monitoring forms for one third of the consumers whose
files were accessed. In these forms, substantial data were
missing. This finding suggests that inadequate monitor-
ing of metabolic risk factors reported in studies under-
taken in mental health services in metropolitan area of
Australia [28–30, 46] may be applicable to regionally-
located services. Consistent with other studies [27, 28]
the absence of waist circumference data in many con-
sumer files was also observed in this study.
Several factors may have contributed to the limited
use of the form. Firstly, forms may not have been
present in some electronic files because those consumers
may not have had contact with the health service since
the implementation of the routine metabolic monitoring
form. Secondly, although service policy was that the
electronic forms were to be used, a period of transition-
ing from paper-based to electronic forms means that
some staff may have continued to use the paper-based
forms. Discussions with the health service, however, in-
dicated that some medication-specific observations (e.g.,
lithium levels) were not routinely conducted or only
conducted in specific cases. Thus, it is unclear if the lim-
ited use of the form results from observations not being
made or data being recorded in paper-based rather than
electronic format. Thirdly, some staff may not have been
trained in the use of the new initiative or may have
Table 3 Medication-specific observations recorded in the metabolic monitoring forms at baseline
Measurea Observation recorded – n (%) Observation not recorded – n (%)
Endocrine Prolactin levelb 27 (10.3) 234 (89.7)
Sodium valproate Full blood count 8 (3.1) 253 (96.9)
Valproate level 26 (10.0) 235 (90.0)
Carbamazepine Full blood count 1 (0.4) 260 (99.6)
Carbamazepine level 3 (1.1) 258 (98.9)
Lithium Thyroid function test 54 (20.7) 207 (79.3)
Lithium level 3 (1.1) 258 (98.9)
Clozapine Clozapine level 40 (15.3) 221 (84.7)
aSpace is also provided on the form to record observations of cardiac function, including electrocardiogram (rate, rhythm, abnormality), echocardiogram
(if consumers are on Clozapine), and troponin. No forms contained observations for these measures
bInstructions on form are to record if consumer is on Risperidone or Amisulpride
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chosen not to use the form based on personal prefer-
ence. Finally, some consumers may have exercised their
right to refuse to participate in some or all routine tests.
This last point is important and highlights a limitation
in the current form in that a consumer’s refusal is not
record and this may have contributed to the low report-
ing of some measures.
There are a number of service-level strategies that
may advance the use of electronic metabolic monitoring
forms to better manage the physical health care of
people with SMI. For example, regular and ongoing au-
dits to manage the transition from paper-based to elec-
tronic metabolic monitoring records could be initiated
and linked to key performance indicators. These audits
should identify additional information of interest, includ-
ing the pharmacotheraputic outcomes and adverse
events, and incorporate electronic flagging of results that
are outside reference ranges, to ensure follow up and
early intervention. Nurses, for example, with their holis-
tic training, may be well-placed to facilitate a multidis-
ciplinary approach to the mental and physical healthcare
of mental health consumers [47]. Notably, a high num-
ber of nurses in mental health recognise physical health
care as an important part of their role and express inter-
est in ongoing education and training on cardiovascular
health and diabetes [48]. Indeed, a number of studies
have demonstrated the success of specialist nursing roles
for coordinating the physical health care of mental
health consumers [23, 26, 30]. Integration of these roles
in to routine practice, however, is not widespread. As a
result, the ongoing physical health care of mental health
consumers in mental health settings remains disjointed.
The findings of the present study are not without limi-
tation. The data for this study were obtained from the
metabolic monitoring forms available in consumers’
electronic health records only. Therefore, we have no
knowledge of the medications consumers were taking at
the time data were entered on the form. As such, we are
unable to determine whether metabolic monitoring was
more thorough or more frequent for those consumers
who were taking medications known to increase cardio-
metabolic risks. Equally, we cannot determine if pharma-
cotherapeutic agents for the treatment of hypertension,
hyperglycaemia, hypertriglycidaemia or hypoalphalipo-
protienaemia were used. This limitation, however, high-
lights a significant issue with the current metabolic
monitoring form. More broadly, the extent of missing
data in the metabolic monitoring form suggests that ei-
ther routine testing was not undertaken for some con-
sumers or the data is reported elsewhere. Future studies
in this field should consider the correlates to routine
metabolic monitoring and the effect of clinician training
on use of the form, to enhance its role in clinical
decision-making.
The design of the study (a retrospective file audit) does
not facilitate an understanding of the reasons why not
all measures were present on the form. In mental health
care services potential reasons for not undertaking or
reporting data on metabolic risks include time con-
straints, views that screening can negatively affect
rapport building, and absence of equipment [27, 46].
Qualitative research with nurses within mental health
care indicate an awareness of the physical health prob-
lems experienced by people with SMI [49–51]. However,
nurses express concerns regarding physical health care
such as competing priorities, role delineation, and access
to physical health interventions for consumers [49]. In
an interview study that included nurses (n = 21), Ehrlich
et al. [51] came to an overriding theme of “care bound-
aries” that nurses needed to navigate, as those boundar-
ies shaped their individual agency to provide physical
health care. The boundaries included “the illness (e.g.
acuity), care provision processes (e.g. professional scope
of practice), sectors (i.e. government, non-government,
and private), the health-care system (e.g. funding con-
straints), and society (e.g. societal norms surrounding
mental illness)” ([51], p. 245).
Conclusions
Inadequate physical health care of people with SMI is
acknowledged as a widespread issue [52]. The present
study demonstrates that a routine metabolic monitoring
form placed in the consumers electronic health record
was not utilised in a manner that maximises its potential
benefit to the consumer or the health service. A great
deal of missing data is evident and interventions or
treatments to address metabolic abnormalities are not
recorded on the form. Concerted, systematic changes
are required within mental health services so that con-
sumers can enjoy their right to equitable healthcare.
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